| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2009;53:701.)
© 2009 American Heart Association, Inc.
Original Articles |
From the Departments of Pathophysiology Laboratory Sciences (M.M., H.Y., K.T., M.O.) and Cardiology (T.N., T. Murohara), Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Medical Technology (M.F., K.H., T.Y., T.K., T. Murate, Y.K., K.N.), Nagoya University School of Health Sciences, Nagoya, Japan; Aichi-Gakuin University School of Dentistry (M.Y.), Nagoya, Japan.
Correspondence to Kohzo Nagata, Department of Medical Technology, Nagoya University School of Health Sciences, 1-1-20 Daikominami, Higashi-ku, Nagoya 461-8673, Japan. E-mail nagata{at}met.nagoya-u.ac.jp
| Abstract |
|---|
|
|
|---|
isoform of phosphatidylinositol 3-kinase was decreased, whereas those of the p110
isoform of phosphatidylinositol 3-kinase and the phosphorylation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase were increased, in the heart of sedentary rats, and all of these effects were prevented by exercise. Thus, exercise training had a beneficial effect on cardiac remodeling and attenuated heart failure in hypertensive rats, with these effects likely being attributable to the attenuation of left ventricular concentricity and restoration of coronary angiogenesis through activation of phosphatidylinositol 3-kinase(p110
)-Akt-mammalian target of rapamycin signaling.
Key Words: hypertension sodium-dependent heart failure exercise hypertrophy rats Dahl coronary angiogenesis
| Introduction |
|---|
|
|
|---|
The serine-threonine protein kinase Akt is an important mediator of phosphatidylinositol 3-kinase (PI3K) signaling and regulates multiple cellular functions.2 PI3K-Akt signaling is implicated in the regulation of cardiac growth, contractile function, and coronary angiogenesis.3–5 A mismatch between the number of coronary capillaries and the size of cardiomyocytes, resulting in myocardial hypoxia, is thought to develop during the progression of cardiac hypertrophy.6 Indeed, studies have indicated the existence of a relation among cardiac angiogenesis, hypertrophy, and function.7,8 Attenuation of coronary angiogenesis in the setting of load-induced cardiac growth may, thus, play an important role in the development of cardiac pathology, with the balance between cardiac growth and coronary angiogenesis, rather than the extent of hypertrophy, per se, being a key determinant of the transition from physiological to pathological hypertrophy.2 Antiangiogenic activity of the tumor suppressor protein p53 has been implicated recently in the transition from cardiac hypertrophy to heart failure.9
The cardioprotective effects of exercise training are well established. Studies have suggested that carefully applied programs of exercise in patients with heart failure are generally safe and may improve exercise tolerance, vascular endothelial function, central cardiac function, and overall quality of life.10,11 Exercise training also appears to improve survival in patients or animal models with heart failure.12–14 However, the mechanism underlying such efficacy has remained unclear.
We have now investigated the effects of exercise training on cardiac growth, contractile function, and coronary angiogenesis, as well as on PI3K-Akt signaling in a rat model of hypertension-induced heart failure. We hypothesized that exercise training might alter left ventricular (LV) geometry and induce myocardial angiogenesis and that such effects might contribute to amelioration of heart failure.
| Methods |
|---|
|
|
|---|
Echocardiographic and Hemodynamic Analyses
Systolic blood pressure (SBP) and heart rate (HR) were measured weekly in conscious animals by tail-cuff plethysmography (BP-98A; Softron). At 18 weeks of age, rats were subjected to transthoracic echocardiography, as described previously.15 Details of echocardiographic analysis are available in the online data supplement. After echocardiography, cardiac catheterization was performed as described previously.16 Tracings of LV pressure and the ECG were digitized to determine LV end-diastolic pressure.
Tissue Preparation
For details, please see the online data supplement.
Histology and Immunohistochemistry
The left ventricle was fixed in ice-cold 4% paraformaldehyde for 48 to 72 hours, embedded in paraffin, and processed for histology and immunohistochemistry, as described.17 Sections were stained with mouse monoclonal antibodies to the endothelial cell marker CD31 (diluted 1:100; Pharmingen) to determine the extent of coronary capillary formation. Individual endothelial cells or clusters of endothelial cells, with or without a lumen, were regarded as capillaries. Capillary density was expressed as the average number of capillaries per square millimeter. The ratio of the number of coronary capillaries to that of cardiomyocytes was also determined. All of the image analysis was performed with National Institutes of Health Scion Image software. Details are available in the online data supplement.
Quantitative RT-PCR Analysis
Total RNA was extracted from LV tissue and subjected to quantitative RT-PCR analysis, as described,18 with primers and TaqMan probes specific for rat complementary DNAs encoding hypoxia-inducible factor (HIF) 1
(5'-ACTGCACAGGCCACATTCATG-3', 5'-CAGCACCAAGCACGTCATAGG-3', and 5'-ACCAGCAGTAACCAGCCGCAGTGTG-3' as the forward primer, reverse primer, and TaqMan probe, respectively; GenBank accession No. NM_024359), vascular endothelial growth factor (VEGF),19 and endothelial NO synthase.20 Reagents for detection of human 18S rRNA (Applied Biosystems) were used to quantify rat 18S rRNA as an internal standard. Details are available in the online data supplement.
Immunoblot Analysis
Total protein was isolated from LV tissue and quantitated with the Bradford reagent (Bio-Rad). Equal amounts of the total protein fraction were subjected to SDS-PAGE, and the separated proteins were transferred to a polyvinylidene difluoride membrane, as described previously.20 The membrane was incubated with a 1:1000 dilution of rabbit polyclonal antibodies to the p110
isoform of PI3K, the p110
isoform of PI3K, Akt, Akt phosphorylated on Ser473, mammalian target of rapamycin (mTOR), mTOR phosphorylated on Ser2448, p70 S6 kinase, p70 S6 kinase phosphorylated on Thr389, p38 mitogen-activated protein kinase (MAPK), p38 MAPK phosphorylated on Thr180 and Tyr182, extracellular signal-regulated kinase (ERK) 1 and 2, or ERK1/2 phosphorylated on Thr202 and Tyr204 (Cell Signaling Technology) and a dilution of a goat polyclonal antibody to GAPDH (Santa Cruz Biotechnology). It was then exposed to a 1:1000 dilution of horseradish peroxidase–conjugated goat antibodies to rabbit immunoglobulin G (Medical and Biological Laboratories), after which immune complexes were detected and quantified as described previously.20
Statistical Analysis
Data are presented as means±SEMs. Differences among groups were assessed by 1-way factorial ANOVA; if a significant difference was detected, intergroup comparisons were performed with Fishers multiple-comparison test. The time courses of SBP and HR were compared among groups by 2-way, repeated-measures ANOVA. Survival rate was analyzed by the standard Kaplan–Meier method with a log-rank test. A P value of <0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
Echocardiography revealed that the interventricular septum thickness, LV posterior wall thickness, LV fractional shortening, LV mass, and the relative wall thickness (RWT) were significantly greater and that LV end-diastolic dimension was significantly smaller in the HF group than in the CNT group (Table 2 and Figure 2A). Exercise training did not affect LV mass, but it significantly attenuated the changes in interventricular septum thickness, LV posterior wall thickness, LV fractional shortening, RWT, and LV end-diastolic dimension. Hemodynamic analysis revealed that LV end-diastolic pressure was significantly increased in the HF group compared with the CNT group and that exercise training attenuated the load-induced increase in LVEDP (Table 1). Hemodynamic overload resulted in a rightward and upward shift in the plot of RWT versus LV mass, whereas exercise training resulted in a downward shift with a slight shift to the left in this plot (Figure 2B). These data indicate that exercise training attenuated LV concentricity without affecting LV mass or impairing cardiac function.
|
|
Cardiac Fibrosis and Coronary Angiogenesis
Histological analysis revealed marked interstitial fibrosis in the left ventricle of rats in the HF group compared with those in the CNT group. This increase in cardiac fibrosis was significantly reduced by exercise training (Table 2).
Immunostaining of the myocardium with antibodies to CD31 to detect capillary endothelial cells revealed that capillary density was decreased in the HF group as a result of the pronounced cardiac hypertrophy and that exercise training restored capillary density to the level apparent in the CNT group despite the remaining cardiac hypertrophy (Figure 3A and 3B). The ratio of the number of coronary capillaries to that of cardiomyocytes was slightly but significantly increased in the HF group compared with the CNT group, and exercise training induced an additional increase in this ratio (Figure 3C).
|
Activation of Proangiogenic Signaling
The myocardial abundance of the p110
isoform of PI3K was markedly reduced, whereas that of the p110
isoform of PI3K was significantly increased, in the HF group compared with the CNT group. These changes in PI3K isoform expression were prevented by exercise training (Figure 4A and 4B). The ratio of the amount of the phospho-Ser473 form of Akt to that of total Akt was significantly increased in the HF group compared with the CNT group, and exercise training resulted in a further increase in this ratio (Figure 4C). The phosphorylation of mTOR on Ser2448 was also increased in the HF group compared with the CNT group and was increased further by exercise training (Figure 4D). The phosphorylation of p70 S6 kinase on Thr389 was significantly increased in the HF group compared with the CNT group, but it was not affected further by exercise training (Figure 4E). The phosphorylation levels of both p38 MAPK and ERK1/2 were significantly increased in the HF group compared with the CNT group, and these effects were prevented by exercise training (Figure 4F and 4G). Finally, the amounts of HIF-1
, VEGF, and endothelial NO synthase mRNAs in the left ventricle were markedly reduced in the HF group compared with the CNT group, and these changes were prevented by exercise training (Figure 5).
|
|
| Discussion |
|---|
|
|
|---|
)-Akt-mTOR signaling pathway. Exercise training did not significantly affect SBP during the experimental period, although the increase in SBP induced by the high-salt diet was slightly attenuated for several weeks after the initiation of exercise, consistent with previous observations in spontaneously hypertensive rats and heart failure rats.13,14,21 Exercise training increases venous return, leading to an increase in cardiac output, contributing to the preserved hypertension, especially in the setting of high salt intake. The responses of SBP to exercise, thus, likely depend on the form and the intensity and duration of exercise or on the extent of chronic volume load. HR was significantly lowered by exercise training during the initial few weeks. Exercise training increases baroreflex and overall vagal activity, and a slow HR at rest is in general associated with greater longevity.22 Indeed, exercise training inhibited the development of heart failure and increased survival rate in the present model of hypertension, consistent with the results of previous studies showing that exercise training induces bradycardia and improves survival in hypertensive rat models.13,14,21,23 The return to an increasing HR at 13 weeks in the Ex group in the present study might be attributable to the progression of cardiac pathophysiology resulting from persistent severe hypertension.
The adaptations induced by exercise training, including physiological hypertrophy, may be regarded as compensatory responses to a chronic volume load. Patients with essential hypertension manifest 4 different patterns of LV geometry in terms of LV mass and RWT.24 Mortality and the frequency of cardiovascular events are highest in patients with concentric hypertrophy and intermediate in those with eccentric hypertrophy.24–26 In the present study, exercise training attenuated LV concentricity without affecting LV mass or impairing cardiac function. It thereby attenuated heart failure and increased survival in hypertensive DS rats, consistent with previous observations with other animal models of hypertension.13,14 The physiological form of cardiac hypertrophy is an adaptive response to long-term exercise training, whereas the pathological form is often a maladaptive response to provocative stimuli, such as hypertension and aortic stenosis.3 The physiological hypertrophy apparent in the heart of athletes manifests as eccentric hypertrophy.
The progression to heart failure is typically associated with increased fibrosis and disruption of normal cellular organization in the LV myocardium.27,28 Exercise training reduced the extent of interstitial fibrosis in the left ventricle of hypertensive DS rats, consistent with the notion that physiological hypertrophy is not associated with interstitial fibrosis.2,3 The attenuation of LV concentricity observed in the Ex group, thus, likely reflects a compensatory morphological response to maintain cardiac function.
The balance between cardiac growth and coronary angiogenesis is a key determinant of cardiac function, with disturbance of this balance being implicated in the transition from adaptive hypertrophy to heart failure.29 Physiological cardiac hypertrophy is associated with a normal or increased number of myocardial capillaries, whereas pathological hypertrophy is associated with a reduction in capillary density.30 Indeed, myocardial capillary density is reduced in patients with heart disorders, eg, aortic stenosis, dilated cardiomyopathy, or ischemic cardiomyopathy.31,32 In the present study, exercise training reduced the extent of cardiac interstitial fibrosis and restored coronary capillary density, as well as attenuated LV concentricity in hypertensive DS rats. In addition, exercise training induced a further increase in the ratio of the number of coronary capillaries to that of cardiomyocytes in these animals. These data are consistent with those of previous studies showing that capillary density was increased in the hypertrophic left ventricle by exercise training.21,33 The exercise-induced normalization of the imbalance between cardiac growth and coronary angiogenesis may, thus, have contributed to the preservation of cardiac function and the consequent improvement in the survival of hypertensive DS rats.
Akt is activated by various extracellular stimuli in a PI3K-dependent manner and regulates multiple aspects of cellular functions, including survival, growth, and metabolism.2 Akt is required for physiological cardiac growth.3 However, in Akt transgenic mice, long-term Akt activation results in excessive cardiac hypertrophy associated with pathological remodeling and loss of contractile function.29 Akt is activated by the p110
isoform of PI3K in the induction of physiological hypertrophy, but it is also activated by the p110
isoform of PI3K in response to various agonists of G protein–coupled receptors, eg, endothelin 1, in the induction of pathological hypertrophy.4 It is, therefore, unlikely that PI3K-Akt signaling is the sole determinant of physiological versus pathological hypertrophy. It is possible, however, that the intensity or duration of signaling mediated by p110
differs from that mediated by p110
and that such a difference contributes to the induction of physiological versus pathological hypertrophy.34 In the present study, the abundance of p110
was markedly reduced, whereas that of p110
was significantly increased, in the left ventricle of HF rats. In addition, the increase in the phosphorylation levels of Akt and mTOR in HF rats was not accompanied by an increase in myocardial capillary density. Furthermore, the activation of p38 MAPK and ERK apparent in the HF group is indicative of the development of pathological hypertrophy.5,34 In contrast, exercise training inhibited the isoform shift of PI3K, as well as the activation of p38 MAPK and ERK, with these effects likely underlying both the prevention of the decrease in myocardial capillary density and the further increase in the extents of Akt and mTOR phosphorylation. Exercise activates the insulin-like growth factor 1-PI3K(p110
) pathway, and it has been shown that PI3K(p110
) plays a critical role in the induction of cardiac growth induced by exercise training.5 The p110
isoform of PI3K has also been suggested to inhibit signaling at the level of G protein–coupled receptors or G proteins.4 It is, thus, likely that physiological stimuli (eg, exercise training) cannot only switch on the IGF1-PI3K(p110
) pathway but also switch off the G protein–coupled receptor agonist-PI3K(p110
) pathway activated by pathological stimuli (eg, pressure overload).4 Together, these observations suggest that exercise training reduced the imbalance between cardiac growth and angiogenesis through activation of the PI3K(p110
)-Akt-mTOR pathway.
VEGF is a central regulator of angiogenesis. Akt-induced expression of VEGF is mediated by activation of mTOR and consequent upregulation of HIF-1.35 The mTOR-dependent expression of VEGF is upregulated during the physiological phase of cardiac growth but is downregulated during the pathological phase of cardiac hypertrophy.29 In the present study, the increase in the phosphorylation of mTOR was accompanied by phosphorylation of p70 S6 kinase in the left ventricle of HF rats. However, the abundance of HIF-1
, VEGF, and endothelial NO synthase mRNAs was reduced in the left ventricle of these animals. Exercise-induced stimulation of Akt-mTOR signaling was associated with restoration of the expression of the genes for these proangiogenic proteins. The phosphorylation of p70 S6 kinase was not affected by exercise training. These data suggest that short-term Akt activation promotes coronary angiogenesis in a manner dependent on mTOR and that long-term activation of Akt-mTOR signaling results in its uncoupling from stimulation of the expression of proangiogenic proteins, leading to impaired coronary angiogenesis and excessive growth of the heart.29 The underlying mechanisms responsible for exercise-induced restoration of coronary angiogenesis remain to be determined. It is possible that the increase in coronary blood flow and sheer stress induced by exercise training improves vascular endothelial function or that the antioxidant or anti-inflammatory effects of exercise training result in inhibition of myocardial fibrosis and stimulation of coronary capillary formation.
With regard to limitations of the present study, we did not assess whether the intensity of exercise used was the most appropriate in this model of hypertension. The duration of exercise training was based on previous observations,21 but the efficacy of shorter durations of exercise has also been demonstrated.13,14 Excessive long-term exercise was shown to promote cardiac fibrosis and to have deleterious effects on cardiac remodeling28,36 or to lead to bronchial congestion resulting from increased left atrial pressure,37 possibly accelerating the progression to heart failure. Recently, the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training Trial demonstrated that an exercise training program in patients with heart failure is safe and may contribute to the reduction of clinical events but does not improve the short-term survival.38 Exercise regimens must, therefore, be carefully calibrated for clinical application to heart failure.39
Perspectives
We have shown that exercise training had a beneficial effect on cardiac remodeling and attenuated heart failure in hypertensive DS rats. It promoted coronary angiogenesis mediated by PI3K(p110
)-Akt-mTOR signaling and attenuated LV concentricity and inhibited myocardial fibrosis, leading to the preservation of cardiac function and improved survival. Given that the balance between cardiac growth and angiogenesis is a key determinant of cardiac function, it may be advantageous to stimulate angiogenesis as part of a general strategy to prevent or reverse heart failure. It may be possible to treat hypertension and heart failure with a combination of antihypertrophic (antihypertensive drugs) and proangiogenic (exercise training) protocols, with the combined therapy being more effective than either treatment alone.
| Acknowledgments |
|---|
This work was supported by unrestricted research grants from Takeda Pharmaceutical Co Ltd (Osaka, Japan), Chugai Pharmaceutical Co Ltd (Tokyo, Japan), and Kyowa Hakko Kogyo Co, Ltd (Tokyo, Japan), and by Management Expenses Grants from the government to Nagoya University.
We thank Ayako Fukata, Yuriko Kato, and Yurie Kasai for technical assistance.
Disclosures
None.
Received November 29, 2008; first decision December 19, 2008; accepted February 6, 2009.
| References |
|---|
|
|
|---|
2. Shiojima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 2006; 20: 3347–3365.
3. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, Muslin AJ. Akt1 is required for physiological cardiac growth. Circulation. 2006; 113: 2097–2104.
4. McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY, Jennings GL. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 2007; 104: 612–617.
5. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, Izumo S. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A. 2003; 100: 12355–12360.
6. Tomanek RJ. Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol. 1990; 15: 528–533.[Abstract]
7. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001; 7: 430–436.[CrossRef][Medline] [Order article via Infotrieve]
8. Brown MD, Davies MK, Hudlicka O. Angiogenesis in ischaemic and hypertrophic hearts induced by long-term bradycardia. Angiogenesis. 2005; 8: 253–262.[CrossRef][Medline] [Order article via Infotrieve]
9. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007; 446: 444–448.[CrossRef][Medline] [Order article via Infotrieve]
10. Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, Sullivan MJ. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation. 2003; 107: 1210–1225.
11. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen O, Skjaerpe T. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007; 115: 3086–3094.
12. Smart N, Marwick TH. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med. 2004; 116: 693–706.[CrossRef][Medline] [Order article via Infotrieve]
13. Emter CA, McCune SA, Sparagna GC, Radin MJ, Moore RL. Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats. Am J Physiol Heart Circ Physiol. 2005; 289: H2030–H2038.
14. Chicco AJ, McCune SA, Emter CA, Sparagna GC, Rees ML, Bolden DA, Marshall KD, Murphy RC, Moore RL. Low-intensity exercise training delays heart failure and improves survival in female hypertensive heart failure rats. Hypertension. 2008; 51: 1096–1102.
15. Hayashi K, Kimata H, Obata K, Matsushita A, Fukata A, Hashimoto K, Noda A, Iwase M, Koike Y, Yokota M, Nagata K. Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters. J Card Fail. 2008; 14: 238–244.[CrossRef][Medline] [Order article via Infotrieve]
16. Kato MF, Shibata R, Obata K, Miyachi M, Yazawa H, Tsuboi K, Yamada T, Nishizawa T, Noda A, Cheng XW, Murate T, Koike Y, Murohara T, Yokota M, Nagata K. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt. J Hypertens. 2008; 26: 1669–1676.[CrossRef][Medline] [Order article via Infotrieve]
17. Nagata K, Somura F, Obata K, Odashima M, Izawa H, Ichihara S, Nagasaka T, Iwase M, Yamada Y, Nakashima N, Yokota M. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. Hypertension. 2002; 40: 168–174.
18. Somura F, Izawa H, Iwase M, Takeichi Y, Ishiki R, Nishizawa T, Noda A, Nagata K, Yamada Y, Yokota M. Reduced myocardial sarcoplasmic reticulum Ca2+-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy. Circulation. 2001; 104: 658–663.
19. Inoue K, Sakurada Y, Murakami M, Shirota M, Shirota K. Detection of gene expression of vascular endothelial growth factor and flk-1 in the renal glomeruli of the normal rat kidney using the laser microdissection system. Virchows Arch. 2003; 442: 159–162.[CrossRef][Medline] [Order article via Infotrieve]
20. Xu J, Nagata K, Obata K, Ichihara S, Izawa H, Noda A, Nagasaka T, Iwase M, Naoe T, Murohara T, Yokota M. Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats. Hypertension. 2005; 46: 719–724.
21. Ziada AM, Hassan MO, Tahlilkar KI, Inuwa IM. Long-term exercise training and angiotensin-converting enzyme inhibition differentially enhance myocardial capillarization in the spontaneously hypertensive rat. J Hypertens. 2005; 23: 1233–1240.[Medline] [Order article via Infotrieve]
22. Iellamo F, Legramante JM, Massaro M, Raimondi G, Galante A. Effects of a residential exercise training on baroreflex sensitivity and heart rate variability in patients with coronary artery disease: a randomized, controlled study. Circulation. 2000; 102: 2588–2592.
23. Melo RM, Martinho E Jr, Michelini LC. Training-induced, pressure-lowering effect in SHR: wide effects on circulatory profile of exercised and nonexercised muscles. Hypertension. 2003; 42: 851–857.
24. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114: 345–352.
25. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992; 19: 1550–1558.[Abstract]
26. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Santucci A, Santucci C, Reboldi G, Porcellati C. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol. 1996; 78: 197–202.[Medline] [Order article via Infotrieve]
27. Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension. 2006; 47: 656–664.
28. Schultz RL, Swallow JG, Waters RP, Kuzman JA, Redetzke RA, Said S, de Escobar GM, Gerdes AM. Effects of excessive long-term exercise on cardiac function and myocyte remodeling in hypertensive heart failure rats. Hypertension. 2007; 50: 410–416.
29. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005; 115: 2108–2118.[CrossRef][Medline] [Order article via Infotrieve]
30. Hudlicka O, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 1992; 72: 369–417.
31. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation. 1992; 86: 38–46.
32. Karch R, Neumann F, Ullrich R, Neumuller J, Podesser BK, Neumann M, Schreiner W. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy. Cardiovasc Pathol. 2005; 14: 135–144.[CrossRef][Medline] [Order article via Infotrieve]
33. Crisman RP, Rittman B, Tomanek RJ. Exercise-induced myocardial capillary growth in the spontaneously hypertensive rat. Microvasc Res. 1985; 30: 185–194.[CrossRef][Medline] [Order article via Infotrieve]
34. Dorn GW II, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest. 2005; 115: 527–537.[CrossRef][Medline] [Order article via Infotrieve]
35. Land SC, Tee AR. Hypoxia-inducible factor 1
is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem. 2007; 282: 20534–20543.
36. Sarma S, Schulze PC. Exercise as a physiologic intervention to counteract hypertension: can a good idea go bad? Hypertension. 2007; 50: 294–296.
37. Roulaud M, Donal E, Raud-Raynier P, Denjean A, de Bisschop C Does exercise have deleterious consequences for the lungs of patients with chronic heart failure? Respir Med. 2009; 103: 393–400.[CrossRef][Medline] [Order article via Infotrieve]
38. Mollmann H, Nef H, Bohm M, Laufs U. Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association. Clin Res Cardiol. 2009; 98: 1–7.[CrossRef][Medline] [Order article via Infotrieve]
39. Tai MK, Meininger JC, Frazier LQ. A systematic review of exercise interventions in patients with heart failure. Biol Res Nurs. 2008; 10: 156–182.
Related Article:
Hypertension 2009 53: 600-601.
This article has been cited by other articles:
![]() |
B.ņa Benito and S. Nattel Exercise training as a treatment for heart failure: potential mechanisms and clinical implications J. Physiol., November 1, 2009; 587(21): 5011 - 5013. [Full Text] [PDF] |
||||
![]() |
S. N. Thornton and K. Hess Exercise Generates Lactate and Fluid Intake: Effects on Mitochondrial Function in Heart and Vascular Smooth Muscle Hypertension, August 1, 2009; 54(2): e14 - e14. [Full Text] [PDF] |
||||
![]() |
M. Miyachi and K. Nagata Response to Exercise Generates Lactate and Fluid Intake: Effects on Mitochondrial Function in Heart and Vascular Smooth Muscle Hypertension, August 1, 2009; 54(2): e15 - e15. [Full Text] [PDF] |
||||
![]() |
P. C. Schulze Beneficial Effects of Moderate Exercise in Arterial Hypertension Hypertension, April 1, 2009; 53(4): 600 - 601. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |